EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma
Clinical trial NCT06390059 · COMPLETED
Trial details
- NCT number
- NCT06390059
- Sponsor
- NovoCure Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-28
- Primary completion
- 2025-11-18
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.